Apelin, a novel. adipokine over-produced in obesity:: Friend or foe?

被引:56
作者
Castan-Laurell, I [1 ]
Boucher, J [1 ]
Dray, C [1 ]
Daviaud, D [1 ]
Guigné, C [1 ]
Valet, P [1 ]
机构
[1] Univ Toulouse 3, INSERM, U586, Unite Rech Obes,Inst Louis Bugnard,IFR 31, F-31432 Toulouse, France
关键词
D O I
10.1016/j.mce.2005.09.012
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
[No abstract available]
引用
收藏
页码:7 / 9
页数:3
相关论文
共 27 条
[1]   The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo [J].
Ashley, EA ;
Powers, J ;
Chen, M ;
Kundu, R ;
Finsterbach, T ;
Caffarelli, A ;
Deng, A ;
Eichhorn, J ;
Mahajan, R ;
Agrawal, R ;
Greve, J ;
Robbins, R ;
Patterson, AJ ;
Bernstein, D ;
Quertermous, T .
CARDIOVASCULAR RESEARCH, 2005, 65 (01) :73-82
[2]   Apelin has in vivo inotropic effects on normal and failing hearts [J].
Berry, MF ;
Pirolli, TJ ;
Jayasankar, V ;
Burdick, J ;
Morine, KJ ;
Gardner, TJ ;
Woo, YJ .
CIRCULATION, 2004, 110 (11) :II187-II193
[3]   Apelin, a newly identified adipokine up-regulated by insulin and obesity [J].
Boucher, J ;
Masri, B ;
Daviaud, D ;
Gesta, S ;
Guigné, C ;
Mazzucotelli, A ;
Castan-Laurell, I ;
Tack, I ;
Knibiehler, B ;
Carpéné, C ;
Audigier, Y ;
Saulnier-Blache, JS ;
Valet, P .
ENDOCRINOLOGY, 2005, 146 (04) :1764-1771
[4]  
Brunner L, 1998, Curr Opin Clin Nutr Metab Care, V1, P565, DOI 10.1097/00075197-199811000-00015
[5]   Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction [J].
Chen, MM ;
Ashley, EA ;
Deng, DXF ;
Tsalenko, A ;
Deng, A ;
Tabibiazar, R ;
Ben-Dor, A ;
Fenster, B ;
Yang, E ;
King, JY ;
Fowler, M ;
Robbins, R ;
Johnson, FL ;
Bruhn, L ;
McDonagh, T ;
Dargie, H ;
Yakhini, Z ;
Tsao, PS ;
Quertermous, T .
CIRCULATION, 2003, 108 (12) :1432-1439
[6]   Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats [J].
Cheng, X ;
Cheng, XS ;
Pang, CCY .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 470 (03) :171-175
[7]   Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release [J].
De Mota, N ;
Goazigo, ARL ;
El Messari, S ;
Chartrel, N ;
Roesch, D ;
Dujardin, C ;
Kordon, C ;
Vaudry, H ;
Moos, FO ;
Llorens-Cortes, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (28) :10464-10469
[8]   Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure [J].
Földes, G ;
Horkay, F ;
Szokodi, I ;
Vuolteenaho, O ;
Ilves, M ;
Lindstedt, A ;
Mäyränpää, M ;
Sármán, B ;
Seres, L ;
Skoumal, R ;
Lakó-Futó, Z ;
deChâtel, R ;
Ruskoaho, H ;
Tóth, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 308 (03) :480-485
[9]   Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding [J].
Heinonen, MV ;
Purhonen, AK ;
Miettinen, P ;
Pääkkönen, M ;
Pirinen, E ;
Alhava, E ;
Åkerman, K ;
Herzig, KH .
REGULATORY PEPTIDES, 2005, 130 (1-2) :7-13
[10]   TUMOR-NECROSIS-FACTOR-ALPHA INHIBITS SIGNALING FROM THE INSULIN-RECEPTOR [J].
HOTAMISLIGIL, GS ;
MURRAY, DL ;
CHOY, LN ;
SPIEGELMAN, BM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (11) :4854-4858